Author

Oya Cingöz

Humboldt-Universität zu BerlinORCID 0000-0002-0096-4948Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Bengisu AkbiliD· 1 shared Christine GoffinetiD· 1 shared Dominic WoodingiD· 1 shared Dylan PostmusiD· 1 shared Jenny Jansen· 1 shared Sui Ting Hui· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Bengisu AkbilORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Synergistic latency reversal by the IAP antagonist AZD5582 and BET inhibitor JQ1, combined with Nef ablation, facilitates immune-mediated elimination of latently HIV-1-infected T-cells

Dylan Postmus, Sui Ting Hui, Bengisu Akbil, Jenny Jansen, Dominic Wooding, Oya Cingöz, Christine Goffinet

This study shows that combining IAP antagonist AZD5582, BET inhibitor JQ1, and Nef ablation enhances immune-mediated elimination of HIV-1 latently infected T-cells.

bioRxiv · Aug 6, 2025 · PreprintMicrobiology